Noninvasive tests can reliably detect advanced fatty liver scarring

Two major international studies have delivered the strongest evidence yet on which noninvasive tests can accurately diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, and measure how serious it is. The findings could reduce doctors' reliance on liver biopsies when assessing advanced liver scarring.